Troglitazone suppresses cell growth of myeloid leukemia cell lines by induction of p21WAF1/CIP1 cyclin-dependent kinase inhibitor
A Sugimura, Y Kiriyama, H Nochi, H Tsuchiya… - Biochemical and …, 1999 - Elsevier
A Sugimura, Y Kiriyama, H Nochi, H Tsuchiya, K Tamoto, Y Sakurada, M Ui, Y Tokumitsu
Biochemical and Biophysical Research Communications, 1999•ElsevierIn a human eosinophilic leukemia cell line, EoL-1, cell proliferation was suppressed by 2-
day treatment with troglitazone. EoL-1 cells treated with troglitazone were arrested and
maintained in the G0/G1 phase in the cell cycle. This suppression correlated with the up-
regulation of mRNA for p21WAF1/CIP1 cyclin-dependent kinase (Cdk) inhibitor. The
inhibitory effects of troglitazone on cell proliferation and expression of p21 mRNA were
observed in a human myelomonocytic cell line, U937, and a human myelomonoblastic cell …
day treatment with troglitazone. EoL-1 cells treated with troglitazone were arrested and
maintained in the G0/G1 phase in the cell cycle. This suppression correlated with the up-
regulation of mRNA for p21WAF1/CIP1 cyclin-dependent kinase (Cdk) inhibitor. The
inhibitory effects of troglitazone on cell proliferation and expression of p21 mRNA were
observed in a human myelomonocytic cell line, U937, and a human myelomonoblastic cell …
In a human eosinophilic leukemia cell line, EoL-1, cell proliferation was suppressed by 2-day treatment with troglitazone. EoL-1 cells treated with troglitazone were arrested and maintained in the G0/G1 phase in the cell cycle. This suppression correlated with the up-regulation of mRNA for p21WAF1/CIP1 cyclin-dependent kinase (Cdk) inhibitor. The inhibitory effects of troglitazone on cell proliferation and expression of p21 mRNA were observed in a human myelomonocytic cell line, U937, and a human myelomonoblastic cell line, KPB-M15. In addition, in EoL-1 cells, p21 protein was induced by troglitazone treatment and the induction was inhibited by protein synthesis inhibitor, cycloheximide. These data suggest that troglitazone inhibits cell proliferation in myeloid leukemia cell lines at least in part by induction of p21 Cdk inhibitor.
Elsevier